FDA Approves Kinase Inhibitor for Treatment of AML
Midostaurin, in combination with chemotherapy, treats acute myeloid leukemia in adults
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Midostaurin, in combination with chemotherapy, treats acute myeloid leukemia in adults
Only registered members have full access to PracticeUpdate content.